Skip to content

COGNITION THERAPEUTICS INC

CGTX

CIK 0001455365 · Biological Products, (No Diagnostic Substances) · Nasdaq

  • COGNITION THERAPUTICS INC (until 2010-12-28)
← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$24.71M
+30.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.36
+62.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$25.37M
Q1 May 2026
Cash
$31.13M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
89.5M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings